Although molecular machineries mediating their activity and specificity have been extensively studied, our understanding of the determinants that govern the differential cytotoxicity of NK cells against distinct epithelial cell targets is still limited. By employing a live-cell FRET reporter and quantitative single cell imaging, we characterized the dynamic phenotypes and rate-limiting kinetics of a panel of normal and epithelial cancer cells to killing by primary human NK cells. We uncovered intriguing target-dependent variability in their sensitivity to three distinct NK cell cytotoxic modes mediated by granzyme, death ligand and the largely unexplored necrosis. While NK-target cell interaction via known inhibitory and activating receptors, in particular the KIRs, largely determined the overall cytotoxic activity, we found the variable sensitivity to distinct NK cell cytotoxic modes was not regulated by individual receptors. Instead, plasma membrane dynamics driven by blebs and/or lamellipodia appeared to control the induction of different cytotoxic modes in a target-specific manner, particularly promoting necrotic killing. Our results point to modulating the membrane dynamics of epithelial cell targets as a viable strategy to control the degree, timing and inflammatory consequences of NK cell killing.
Introduction
Natural Killer (NK) cells detect and kill abnormal cell targets, and are considered a promising immunotherapeutic candidate [1, 2] . Harnessing and stimulating the direct cytotoxic activity of NK cells has attracted growing interest in the recent development of cancer immunotherapy, as diverse tumor cell types showed susceptibility to NK cell killing and targeted therapy and immune checkpoint therapy may also act in part via triggering NK cell response [3] [4] [5] . Tumors are known to harbor large genetic and phenotypic heterogeneity that likely impact their differential interactions with NK cells. However, the mechanistic basis underlying the dynamic control over NK cells' selective killing of distinct target cell types, e.g., normal vs. cancer as well as different types of cancer, such as those with hot vs. cold inflammatory microenvironment, is poorly understood.
NK cells are known to detect abnormal cells by integrating signals from various inhibitory and activating receptors on their cell surfaces [6, 7] . The major inhibitory receptors on NK cells are killer cell immunoglobulin-like receptors (KIRs), which interact with major histocompatibility complex I (MHCI) molecules of the target cells, leading to NK cell "self-tolerance" but activation when encountering "foreign" or transformed targets, such as tumor cells with low MHCI expression. Among the many different NK cell activating receptors, NKG2D has been particularly implicated in NK cell-mediated immunity against tumors [8] . Ligands for NKG2D, such as MICA (MHC class I-related gene A), MICB (MHC class I-related gene B) and ULBP (UL16-binding protein), are expressed in most human tumors [9] , and inhibiting NKG2D function attenuated NK cell cytotoxicity against tumor targets [10] . However, the determinants of overall selectivity of NK cells towards particular cancer cell type in terms of both the extent of cytotoxic response as well as cytotoxic mechanism is still poorly understood. And so far the field has very much focused on molecular determinants, while ignoring possible physical and mechanical determinants.
Upon recognition of abnormal cell targets, NK cells can elicit direct target cell death by 4 three main mechanisms, i.e., lytic granule-mediated apoptosis, death ligand-mediated apoptosis and necrosis [11] [12] [13] . Lytic granule-mediated cytotoxicity is considered the principal cytotoxic pathway of NK cells. Upon formation of NK-target cell immunological synapses, lytic granules release perforin and granzymes into the synapse. Granzymes enter the target cell via perforin channels, where they activate the apoptosis pathway via proteolytic activation of caspases [14] . In addition, NK cells express a variety of death ligands, such as Fas ligand (FasL) and TNF-related apoptosis inducing ligand (TRAIL), which engage cognate death receptors expressed on the target cell surface, triggering death by receptor-mediated extrinsic apoptosis [15, 16] . Target cell death by NK cell-induced necrosis has only been reported in a few studies and its mechanistic basis is still largely unknown [13, 17] .
To unravel the target specificity of NK cell cytotoxicity, in this study we characterized the rate-limiting kinetics and phenotypic heterogeneity of NK cell cytotoxic activity against normal and a variety of epithelial cancer cell targets using quantitative single cell microscopy assays. And we pinpointed the dynamic control over the target dependence of NK cell cytotoxic activity and cytotoxic mechanism. Intriguingly, we found the variable sensitivity of epithelial target cells to overall NK killing was conferred mainly by the inhibitory NK cell ligand, MHCI, but not the various activating NK cell ligands, and the target selectivity of NK cell cytotoxic mechanism, e.g., necrosis vs. apoptosis, was determined by differential plasma membrane dynamics of the epithelial cell targets, instead of the well-known inhibitory/activating signaling machinery.
Results

Target cell type dependence of NK cell cytotoxic dynamics
To investigate mechanisms that underlie target preferences of NK cells, we chose a panel of mammalian epithelial cell lines that exhibited variable sensitivity to primary NK cell killing, including one normal cell line, LO2 (immortalized normal hepatic cell line) and four cancer cell lines, i.e., HeLa (cervix cancer), SMMC-7721 (liver cancer), MCF7 (breast cancer), and U-2 OS (bone cancer). To visualize dynamic response to NK cells, we engineered each epithelial cell line with a fluorescent reporter of granzyme-B activity (GzmB-FRET) as well as a mitochondria reporter of apoptosis (IMS-RP), as reported previously [18] [19] [20] . All NK-target cell co-culture assays were conducted with human primary NK cells purified from healthy blood donors and pre-activated by IL-2 for three days, at an NK-to-target cell ratio of 3:1. Target cell death was scored morphologically by blebbing followed by cell lysis, and the time from NK cell addition to morphological target cell death was plotted as cumulative survival curves. As shown in Figure 1A , the normal cell line, LO2, was the most resistant to NK cell killing, consistent with NK cell's function in eliminating abnormal and cancerous cells. Among the cancer cell lines, SMMC-7721 and MCF7 were the most sensitive, with MCF7 exhibiting the fastest kinetics to cell death.
In addition to variable sensitivity of the epithelial cell lines to overall NK cell killing, we also observed striking difference in their susceptibility to distinct cytotoxic modes of NK cells. The majority of cell death (about 60%) seen in SMMC-7721 were preceded by a loss of the granzyme-B FRET (i.e., an increase of CFP (donor) signal and decrease of YFP (acceptor) signal) followed by mitochondrial outer membrane permeabilization (MOMP), suggesting that NK cells killed SMMC-7721 mainly by the lytic granule cytotoxic pathway and intrinsic apoptosis ( Fig. 1B) . In contrast, NK cell cytotoxicity towards U-2 OS cells mostly did not associate with change in the granzyme-B FRET signal. We have previously characterized this mode of target cell death to be mediated by the death ligand, e.g., FasL, and subsequent 6 extrinsic apoptosis [19] . Intriguingly, we found necrosis, a largely unexplored NK cell cytotoxic mechanism, was the primary cytotoxic mode to trigger cell death in MCF7 cells. As shown in the bottom panel of Figure HeLa and LO2. All target cell lines showed substantial cell death triggered by death ligands of NK cells, ranging from 23% to 57% of the total target cell population, suggesting the death receptor pathway is widespread. In contrast, the extent of cell death activated by the lytic granule and necrosis pathways varied more significantly, ranging from 1% to 54% for the lytic granule mode and 1% to 57% for the necrotic mode. Such large variability in the sensitivity to NK cell killing via lytic granule and necrosis indicated that activation of these two cytotoxic modes may depend on epithelial features that are more cell type specific.
Extent of cytotoxicity, but not cytotoxic mode, correlated with MHCI expression
To investigate the potential molecular determinants underlying the observed variable sensitivity of epithelial cell lines to overall NK cell killing as well as to the distinct NK cell cytotoxic modes, we first profiled the expressions of NK cell-interacting surface molecules 7 known to be involved in activating NK cell cytotoxicity for the target cell panel. These molecules include the human MHCI molecule (HLA-A,B,C), NKG2D ligands (MICA, MICB and ULBP-2,5,6) and DNAM-1 ligands (PVR/CD155 and Nectin-2/CD112) [21] . We also measured the expression of the death receptor Fas and an integrin key for NK cell adhesion, ICAM-1 (CD54), in our analysis by flow cytometry ( Fig. 2A ).
The quantified FACS results showed highly variable expressions of all surface molecules that we profiled between the five target cell lines (Fig. 2B ). The sensitivity of target cell lines to overall NK cell killing correlated relatively well with the expression level of the inhibitory MHCI molecules, and to a much lesser extent with MICB, but did not correlate with the expression of the other NKG2D activating ligands, MICA and ULBPs, or the activating ligands for DNAM-1. Surprisingly, the expression level of Fas did not correlate with the differential sensitivity to the death ligand-mediated NK cell cytotoxicity. Our data thus indicated that the inhibitory strength of KIRs-MHCI may exert the primary control over target cell recognition and overall NK cell cytotoxicity against a particular epithelial target, while control by the activating ligands is less universal and more context-dependent.
However, our data did not show any significant correlative feature that was specific to the three distinct NK cell cytotoxic modes. The only differential ligand expression that may potentially render specificity to necrotic killing is MICB, as the MICB expression level in MCF7, the cell line that was particularly prone to necrotic death, was 5-10 folds higher than that in the other four cell lines. However, RNAi knockdown of MICB in MCF7 cells did not attenuate necrotic death induced by NK cells, indicating MICB expression was not the molecular determinant for the activation of necrotic killing by NK cells (data not shown).
Target dependence of NK cell cytotoxicity on inhibitory and activating receptors
As we did not observe correlation between the expression of well-known NK cell-interacting surface ligands with the sensitivity of different target cell lines to distinct NK 8 cell cytotoxic modes, we next investigated the functional involvement of the key inhibitory and activating receptors on NK cell surface, as the target specificity could be conferred by surface ligands not in the profiling panel as discussed above. The NK cell receptors that we examined included two types of inhibitory receptors, KIRs and NKG2A (CD94), and three activating receptors important for cancer target recognition, including NKG2D (CD314), DNAM-1 (CD226) and NKp46 (CD335) [11, 21] . Specifically, we used neutralizing antibodies to block individual receptors or combination of the receptors and then compared the extent and kinetics of target cell death via the three cytotoxic modes with those under the control condition (i.e., no receptor blocking). As there are several KIRs that recognize different HLA molecules on the target cell surface, we used a broad-spectrum neutralizing antibody against HLA-A, -B and -C to block the interaction of all KIRs and human MHCI molecules as a whole, instead of examining the individual KIR, to simplify the analysis. Figure 3B , noting that relative heights were less accurate when overall killing was low. Therefore, in HeLa, receptor modulation appears to tune the overall cytotoxic activity of NK cells and/or receptivity of targets, but not the precise death pathway. Figure 3C summarized the receptor neutralization results for all three pathways across the five epithelial target cell lines. Here, we plotted the ratio of perturbation versus control.
Intuitively, data points along the diagonal indicated no change relative to the control condition, and the further away the data points were from the diagonal, the larger the effect of the respective receptor inhibition in diverting the cell death response into, or away from, one of the three cytotoxic modes. Similar to HeLa cells, neutralization of the inhibitory KIRs-MHCI interaction exerted strong effect in enhancing cell death response of the other four target cell lines, and loss of NKG2D activity exerted the strongest effect in attenuating target cell death. Double inhibition of NKG2D and DNAM-1 nearly abrogated cell death of U-2 OS, SMMC-7721 and MCF7, the three cell lines that were most sensitive to NK cell killing. However, as of HeLa cells, the three cytotoxic modes were altered approximately in parallel, again showing that receptor modulation tuned overall activity of NK cells much more than activity of one specific death pathway. We also noted that except for MCF7, no other cell line showed significant cell death via necrosis under all receptor perturbation conditions, suggesting that MCF7 cells may have unique cellular features that promote the induction of necrotic killing, which we further examined below.
Membrane dynamics modulate target sensitivity to distinct NK cell cytotoxic modes
Since receptor expression level did not predict which death pathway is preferred, and receptor inhibition did not modulate the fraction of death caused by particular pathway, we sought other phenotypic properties that might predict and modulate individual NK cell cytotoxic pathways. We focused on MCF7 and SMMC-7721 because they had the most distinctive preferences, i.e., MCF7 cells were uniquely sensitive to necrosis, while SMMC-7721 cells were sensitive to lytic granule-mediated intrinsic apoptosis. A distinguishing feature of these cell lines in our movies was differences in plasma membrane dynamics. MCF7 cells exhibited extensive dynamic protrusions driven by membrane blebs and lamellipodia (Fig. 4A) . In contrast, SMMC-7721 cells exhibited only moderate membrane dynamics and the membrane of U-2 OS cells was largely quiet (Fig. 4A ). This observation led us to examine whether differential membrane dynamics of the epithelial cell targets contributed to the activation of distinct cytotoxic modes.
To attenuate the formation of dynamic membrane protrusions, we used either NSC23766, an inhibitor of the small GTPase Rac1, to inhibit actin polymerization-driven lamellipodia, or Y27632, an inhibitor of the Rho Kinase (ROCK), to inhibit contractility-driven membrane blebs [22] [23] [24] . NSC23766 significantly reduced membrane protrusions in both MCF7 and SMMC-7721 cells, as evidenced by the kymograph of cell edge, which showed a relatively smooth edge under NSC23766 as compared to a jagged edge in the control cells (Fig. 4A ). The effect of Y27632, however, diverged in MCF7 and SMMC-7721. MCF7 cells treated with Y27632 showed reduced membrane blebs but longer lamellipodia, a phenotype previously characterized as due to compensatory effects of membrane blebs and lamellipodia [22] . SMMC-7721 treated with Y27632 showed reduced protrusions, but small ruffles remained. Attenuation of membrane dynamics by both NSC23766 and Y27632 changed the primary cell death mode of MCF7 cells from necrosis to death ligand-mediated apoptosis, with NSC23766 exhibiting a slightly stronger effect ( Fig.   11 4B). NSC23766 treatment of SMMC-7721 also resulted in a switch of NK cell killing from lytic granule-mediated apoptosis to death ligand-mediated apoptosis, while Y27632 did not show significant effect on altering the NK cell cytotoxic mode (Fig. 4C ). Our data thus showed inhibiting plasma membrane dynamics of epithelial targets promoted NK cell killing via death ligand-mediated apoptosis, while damping the other two cytotoxic modes.
Next we examined whether increasing membrane dynamics, e.g., in SMMC-7721, would alter NK cell killing from lytic granule-mediated apoptosis to the necrosis mode, similar to MCF7 cells. We noted that SMMC-7721 cells showed extensive membrane blebs when they started to adhere to the cell culture plate surface (Fig. 4D, left panel) . And these blebs disappeared upon complete adherence (Fig. 4A, control) . We thus co-cultured primary NK cells with SMMC-7721 that were trypsinized and seeded onto the culture plate for only 4 hours to investigate the effect of enhanced membrane dynamics, in this case, driven by blebs, on NK cell killing mode. Compared to control SMMC-7721 cells that had adhered to the culture plate for 24 hours, which were mainly (~60%) killed by lytic granule-mediated apoptosis, the majority (~50%) of the short-adherence cells were killed via the necrotic mode ( Fig. 4D, right panel) . And addition of the bleb inhibitor, Y27632, abrogated the increase in necrotic killing of the short-adherence cells (Fig. 4D ). As U-2 OS cells adhered to the culture plate surface very quickly (about 3-5 hours) and did not exhibit prolonged blebs, we were unable to use this experimental strategy to study the effect of enhanced membrane dynamics on promoting lytic granule-mediated apoptosis over the death ligand-mediated mode.
Nonetheless, overall our results suggested that the extent of membrane dynamics exerted a key control over the sensitivity of different epithelial targets to the three distinct NK cell cytotoxic modes.
As necrotic death is associated with membrane rupture, we hypothesized that membrane pores formed by perforin at the NK-target cell conjugation may be involved in triggering the membrane rupture and subsequent necrosis. Moreover, it is possible that a highly dynamic 12 membrane, e.g., in MCF7 cells, facilitated excessive lytic granule transfer, thus resulting in large perforin pores that induced necrotic membrane rupture rather than the more controlled apoptosis catalyzed by granzyme-B. To test the role of lytic granule and perforin in the necrotic mode of NK cell cytotoxicity, we pre-treated primary NK cells with Concanamycin A (CMA), an inhibitor of vacuolar type ATPase (V-ATPase) that attenuated lytic granule transfer, and then co-cultured NK cells with MCF7 cells. As shown in Figure 4E 
Discussion
Our study revealed epithelial cell targets varied not only in their overall sensitivity to primary NK cell killing but also to distinct NK cell cytotoxic modes, providing a new angle to modulate the kinetics and inflammatory consequences of NK cell cytotoxic activity. Target specificity to distinct NK cell cytotoxic modes was found to be not determined by the inhibitory/activating receptor machinery, and exhibited rather constant ratios between modes when overall killing was tuned in both directions. A novel determinant of killing mode identified from our work was the extent of plasma membrane dynamics of the epithelial cell targets. A highly dynamic membrane driven by blebs and/or lamellipodia correlated with mostly necrotic killing in MCF7 cells, though we also noted that the loss of caspase-3 in MCF7 may also contribute to its resistance to the intrinsic apoptosis pathway [25] . In contrast, the lytic granule-mediated and death ligand-mediated cytotoxicity are induced in response to moderate and low membrane dynamics of the target cells. We previously showed the death ligand-mediated killing mode induced more gradual target cell death than the lytic granule mode [19] . Hence, inhibiting/activating membrane dynamics that alter the cytotoxic modes could potentially tune the kinetics and extent of cytotoxic response to NK cells. Moreover, as necrotic death releases cell debris to "inflame" the local microenvironment, altering the NK cell cytotoxic modes, i.e., necrosis vs. apoptosis, by modulating target membrane dynamics can enhance or damp the secondary inflammatory response subsequent to NK cell killing.
This may hold the potential of, e.g., amplifying the anti-tumor effect of adoptive cell transfer therapy beyond primary NK cell killing.
The Rho family of GTPases, e.g., Rac1 and the associated kinases, e.g., ROCK, are involved in key oncogenic signaling pathways, particularly by activating the actomyosin network and promoting cancer invasion and metastasis [26, 27] . Up-regulation of Rac1 activity has been frequently observed in human cancer [28] and Rac1 inhibitor, such as NSC23766 that we used in this study, is being actively pursued as anticancer therapeutic. Our 14 data showed that tuning membrane dynamics by targeting Rac1 and ROCK is an effective strategy to influence the cytotoxic mechanism of NK cells. For cancers with elevated activity of Rac1 and/or Rho/ROCK signaling, they are likely more sensitive to inflammatory killing by NK cells via necrosis. And more controlled, apoptotic killing of NK cells can be achieved by combining with Rac1/ROCK inhibitor. As oncogenic activation of receptor tyrosine kinases (RTKs) and Ras signaling also tends to strongly activate protrusive and contractile membrane activity [29] , inhibitors of the RTK signaling pathways that block such membrane dynamics could also be possibly employed to modulate NK cell cytotoxicity.
Dynamics of the actomyocin network upon formation of the NK-target cell
immunological synapse have been previously studied, demonstrating its functional importance for mediating lytic granule transfer [30, 31] . What is new and unexpected from our study is that we found the degree of actomyosin dynamics determined the activation of distinct NK cell cytotoxic modes. The more active actomyosin network is, the more likely the epithelial cell targets would trigger NK cell killing via necrosis. A quiet actomyosin network did not significantly attenuate the overall cytotoxic activity of NK cells, but alter the cytotoxic mechanism to a slower mode mediated by death ligands. Although the mechanistic link between the strong actomyosin dynamics and necrotic killing is alluded to by our study, it is not completely solved. Based on the CMA results shown in Figure 4E , we speculate that the strong actin and myosin dynamics promote more extensive lytic granule transfer, subsequently allowing more perforin to form large pores to lyse the cells. However, it is also possible that the strong actomyosin dynamics facilitate the actin cytoskeleton to tear the membrane apart. Further study is needed to distinguish these two scenarios and pinpoint the origin of necrotic cytotoxicity of NK cells.
Previous studies have showed Ca 2+ played an important role in mediating lytic granule transfer upon NK-target cell interaction. We confirmed that chelating Ca 2+ by EGTA abrogated both granzyme-B-dependent apoptosis and necrosis induced by primary NK cells 15 in the cell line panel that we studied (data not shown). However, we did not observe high Ca 2+ concentration shifted NK cell killing to the necrosis mode, as reported by Backes et al [13] . Increasing Ca 2+ concentration up to 3.5 mM did not enhance necrotic killing of SMMC-7721 or U-2 OS cells. And Ca 2+ concentration higher than 3.5 mM triggered cell death in the absence of NK cells, possibly due to the high salt concentration and osmotic stress. As Backes et al used suspension cells as NK cell targets, e.g., Jurkat E6-1 and K562, while we used epithelial targets, the difference between our results regarding the role of Ca 2+ in necrotic killing may be due to target cell type variation, i.e., suspension vs. adherence, which is of interest for further study.
The fact that we did not observe correlation between the expression levels of the commonly known NK cell activating ligands and the sensitivity of epithelial cell targets to overall NK cell killing re-affirmed the difficulty of developing biomarker from the cancer-associated activating ligands to predict patient prognosis or their response to NK cell therapy. Counter-intuitively, we found the normal cell line, LO2, which was the most resistant to NK cell cytotoxicity, expressed the highest level of NKG2D ligand, MICA, and also high level of ULPs when compared with the cancer cell lines (Fig. 3B) . Previous clinical studies have also showed that high levels of NKG2D ligands were not associated with the extent of NK cell infiltration into the tumors or better prognosis for patients with breast, lung or ovarian cancers [32] [33] [34] , suggesting that expressions of NK cell activating ligands likely vary significantly between cancer types and tumor context, thus hindering their stand-alone prognostic potential.
Materials and Methods
Isolation of primary NK cells from human blood
Primary human NK cells were isolated from fresh human buffy coat (within 24 hours of blood donation) obtained from the Hong Kong Red Cross, by Ficoll-Paque Plus solution and subsequent negative selection of Peripheral Blood Mononuclear Cells (PBMCs) using the EasySep Human NK Cell Enrichment Kit (STEMCELL Technologies), according to manufacturer's protocol. Only NK cell prep with purity higher than 90% (measured by FACS analysis of CD56 staining) was used for experiments. Fresh human NK cells were cultured for 3 days at a density of 1x10 6 cells/ml in RPMI 1640 medium (Gibco, Thermo Fisher) containing 10 ng/ml recombinant human IL-2 (Gibco, Thermo Fisher), 10% heat-inactivated Fetal Calf Serum (Gibco, Thermo Fisher), 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco, Thermo Fisher), prior to experiments.
Cell lines and cell culture
The live-cell Förster Resonance Energy Transfer (FRET) construct that reports on the granzyme-B proteolytic activity as well as the mitochondrial reporter, IMS-RP, were engineered into the five selected epithelial cell lines by retroviral infection, as described previously [18, 19] . Isogenic clones of the fluorescent reporter cell lines that exhibited cell death response to primary NK cell killing most similar to their respective parental lines were selected for performing the live-cell imaging assays. Cell lines were cultured in appropriate medium supplemented with 10% Fetal Calf Serum, 100 U/ml penicillin and 100 μg/ml streptomycin. Specifically, U-2 OS was maintained in McCoy's 5A (Modified) Medium;
MCF7 was maintained in RPMI 1640 Medium; SMMC-7721, HeLa and LO2 were maintained in Dulbecco's modified Eagles Medium (DMEM). For all co-culture experiments with primary NK cells, the NK-to-target cell ratio of 3:1 were used and 50 ng/ml IL-2 was supplemented in the medium.
Chemicals and neutralizing antibodies
The ROCK inhibitor, Y27632, was purchased from Sigma and used at 5 M. The Rac inhibitor, NSC23766, was from SelleckChem and used at 120 M for MCF7 and 50 M for SMMC-7721. Cells were pre-treated with either Y27632 for 1 hour or NSC23766 for [5] [6] [7] [8] [9] [10] [11] [12] hours before experiments. The inhibitor of vacuolar type ATPase (V-ATPase), Concanamycin A, was from Santa Cruz Biotechnology. To block the activity of various NK cell receptors, the following neutralizing antibodies from Biolegend were used: Purified anti-human HLA-A,B,C antibody (Clone W6/32), CD94 (Clone DX22, ), NKG2D (Clone 1D11), NKp46 (Clone 9E2), and DNAM-1 (Clone 11A8). Except for HLA-A,B,C antibody, which was used at 5 μg/ml, the rest of the antibodies were used at 10 μg/ml. 
Time-lapse microscopy and image analysis
